Literature DB >> 11792811

Nuclear envelope disorganization in fibroblasts from lipodystrophic patients with heterozygous R482Q/W mutations in the lamin A/C gene.

C Vigouroux1, M Auclair, E Dubosclard, M Pouchelet, J Capeau, J C Courvalin, B Buendia.   

Abstract

Dunnigan-type familial partial lipodystrophy (FPLD), characterized by an abnormal body fat redistribution with insulin resistance, is caused by missense heterozygous mutations in A-type lamins (lamins A and C). A- and B-type lamins are ubiquitous intermediate filament proteins that polymerize at the inner face of the nuclear envelope. We have analyzed primary cultures of skin fibroblasts from three patients harboring R482Q or R482W mutations. These cells were euploid and able to cycle and divide. A subpopulation of these cells had abnormal blebbing nuclei with A-type lamins forming a peripheral meshwork, which was frequently disorganized. Inner nuclear membrane protein emerin, an A-type lamin-binding protein, strictly colocalized with this abnormal meshwork. Cells from lipodystrophic patients often had other nuclear envelope defects, mainly consisting of nuclear envelope herniations that were deficient in B-type lamins, nuclear pore complexes, lamina-associated protein 2 beta, and chromatin. The mechanical properties of nuclear envelopes were altered, as judged from the extensive deformations observed in nuclei from heat-shocked cells, and from the low stringency of extraction of their components. These structural nuclear alterations were caused by the lamins A/C mutations, as the same changes were introduced in human control fibroblasts by ectopic expression of R482W mutated lamin A.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11792811     DOI: 10.1242/jcs.114.24.4459

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  81 in total

Review 1.  [Adverse effects of antiretroviral therapy. Aspects of pathogenesis].

Authors:  U Seybold; R Draenert; F D Goebel
Journal:  Internist (Berl)       Date:  2003-06       Impact factor: 0.743

2.  Expression of a mutant lamin A that causes Emery-Dreifuss muscular dystrophy inhibits in vitro differentiation of C2C12 myoblasts.

Authors:  Catherine Favreau; Dominique Higuet; Jean-Claude Courvalin; Brigitte Buendia
Journal:  Mol Cell Biol       Date:  2004-02       Impact factor: 4.272

Review 3.  How do mutations in lamins A and C cause disease?

Authors:  Howard J Worman; Jean-Claude Courvalin
Journal:  J Clin Invest       Date:  2004-02       Impact factor: 14.808

4.  Novel nuclear herniations induced by nuclear localization of a viral protein.

Authors:  Cristen C Hoyt; Ron J Bouchard; Kenneth L Tyler
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

Review 5.  Protein farnesylation and disease.

Authors:  Giuseppe Novelli; Maria Rosaria D'Apice
Journal:  J Inherit Metab Dis       Date:  2012-02-04       Impact factor: 4.982

Review 6.  Nuclear lamins.

Authors:  Thomas Dechat; Stephen A Adam; Pekka Taimen; Takeshi Shimi; Robert D Goldman
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-09-08       Impact factor: 10.005

7.  Evaluation of micronucleus and erythrocytic nuclear abnormalities in Balkan whip snake Hierophis gemonensis.

Authors:  Ivancica Strunjak-Perovic; Duje Lisicic; Rozelindra Coz-Rakovac; Natalija Topic Popovic; Margita Jadan; Vesna Benkovic; Zoran Tadic
Journal:  Ecotoxicology       Date:  2010-08-11       Impact factor: 2.823

8.  Protein isoprenylation regulates osteogenic differentiation of mesenchymal stem cells: effect of alendronate, and farnesyl and geranylgeranyl transferase inhibitors.

Authors:  G Duque; C Vidal; D Rivas
Journal:  Br J Pharmacol       Date:  2011-03       Impact factor: 8.739

9.  LITTLE NUCLEI genes affecting nuclear morphology in Arabidopsis thaliana.

Authors:  Travis A Dittmer; Nicola J Stacey; Keiko Sugimoto-Shirasu; Eric J Richards
Journal:  Plant Cell       Date:  2007-09-14       Impact factor: 11.277

10.  In vivo and in vitro examination of the functional significances of novel lamin gene mutations in heart failure patients.

Authors:  N Sylvius; Z T Bilinska; J P Veinot; A Fidzianska; P M Bolongo; S Poon; P McKeown; R A Davies; K-L Chan; A S L Tang; S Dyack; J Grzybowski; W Ruzyllo; H McBride; F Tesson
Journal:  J Med Genet       Date:  2005-08       Impact factor: 6.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.